By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute for Bioprocessing Research and Training in Ireland and GE Healthcare Life Sciences will develop new biochemical assays for the analysis of therapeutic monoclonal antibodies under an agreement announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.